Article
AstraZeneca's Enhertu wins keenly-anticipated U.S. breast cancer nod
Rating:
0.0
Views:
58
Likes:
1
Library:
1
AstraZeneca and Daiichi Sankyo on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer, and paves the way for billions in sales.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value